PAR2 DOES RACE INFLUENCE A PATIENT'S LIKELIHOOD OF BEING PRESCRIBED SELECTIVE CYCLOOXYGENASE-2 INHIBITORS (COX-2S) VERSUS OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) IN MEDICAID MANAGED CARE PLANS (MCOS)?
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)64917-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64917-0/fulltext
Title :
PAR2 DOES RACE INFLUENCE A PATIENT'S LIKELIHOOD OF BEING PRESCRIBED SELECTIVE CYCLOOXYGENASE-2 INHIBITORS (COX-2S) VERSUS OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS (NSAIDS) IN MEDICAID MANAGED CARE PLANS (MCOS)?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64917-0&doi=10.1016/S1098-3015(10)64917-0
First page :
Section Title :
Open access? :
No
Section Order :
76